Free shipping on all orders over $ 500

TSR-011

Cat. No. M2201

All AbMole products are for research use only, cannot be used for human consumption.

TSR-011 Structure
Synonym:

Belizatinib

Size Price Availability Quantity
5mg USD 105  USD105 In stock
10mg USD 170  USD170 In stock
25mg USD 340  USD340 In stock
50mg USD 480  USD480 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TSR-011 is an orally available ALK inhibitor being developed for the treatment of solid tumors including NSCLC. ALK is known to be involved in certain types of cancers, including subsets of non-small cell lung cancer, neuroblastoma and lymphoma. TSR-011 is a potent inhibitor of both anaplastic lymphoma kinase (ALK) and tropomyosin-related kinases (TRK). Preliminary results after eight weeks of treatment with TSR-011 demonstrated disease control (partial responses plus stable disease) in 11 of 17 (65%) evaluable patients treated with TSR-011.

Chemical Information
Molecular Weight 577.73
Formula C33H44FN5O3
CAS Number 1357920-84-3
Solubility (25°C) 100 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Chia-Chi Lin, et al. A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

[2] Yekaterina B Khotskaya, et al. Targeting TRK family proteins in cancer

[3] Wade T Iams, et al. Anaplastic Lymphoma Kinase as a Therapeutic Target in Non-Small Cell Lung Cancer

[4] Georg Pall. The next-generation ALK inhibitors

[5] Mark M Awad, et al. ALK inhibitors in non-small cell lung cancer: crizotinib and beyond

Related ALK Products
F-1

F-1 is a potent ALK and ROS1 dual inhibitor, suppresses phospho-ALK and its relative downstream signaling pathways, with IC50 values of 2.1 nM, 2.3 nM, 1.3 nM and 3.9 nM for ALKWT, ROS1WT, ALKL1196M and ALKG1202R, respectively.

TL13-22 

TL13-22 is a negative control for TL13-12 and a potent ALK inhibitor with an IC50 of 0.54 nM.

TL13-110 

TL13-110 is a negative control for TL13-112 and a potent ALK inhibitor with an IC50 of 0.34 nM.

ALK inhibitor 2 

ALK inhibitor 2 is a potent pyrimidin ALK inhibitor.

NVL-655 TFA

NVL-655 (ALK-IN-27) TFA is a novel, brain-permeable, selective ALK inhibitor with antitumor activity. For Ba/F3 CLIP1-LTK cells, NVL-655 (ALK-IN-27) TFA has an IC50 of 2.7 nM. It can be used in studies related to ALK-positive non-small cell lung cancer (NSCLC).

  Catalog
Abmole Inhibitor Catalog




Keywords: TSR-011, Belizatinib supplier, ALK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.